Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models

Raised blood C-reactive protein (CRP) level is a predictor of cardiovascular events, but whether blood CRP is causal in the disease process is unknown. The latter would best be defined by pharmacological inhibition of the protein in the context of a randomized case-control study. However, no CRP spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Szalai, Alexander J., McCrory, Mark A., Xing, Dongqi, Hage, Fadi G., Miller, Andrew, Oparil, Suzanne, Chen, Yiu-Fai, Mazzone, Michelle, Early, Richard, Henry, Scott P., Zanardi, Thomas A., Graham, Mark J., Crooke, Rosanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996300/
https://www.ncbi.nlm.nih.gov/pubmed/24803739
http://dx.doi.org/10.1155/2014/353614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996300/
https://www.ncbi.nlm.nih.gov/pubmed/24803739
http://dx.doi.org/10.1155/2014/353614

Ejemplares similares